Innovative life-sciences and pharmaceutical executive with 15-plus years of global market (US, Europe, Asia-Pacific, Middle-East, Latin-America) leadership experience in senior executive roles. Strong track record of success leading enterprise-wide changes, large scale integrations, alignment of R&D functions and Commercial functions (e.g., HEOR and Pricing, Reimbursement, Market Access) ensuring stakeholders-centric pipeline development to maximize market uptake potential, developing new capabilities to increase commercial success, and creative and innovative, never-tested before PR&A solutions; changes in strategic direction have resulted worldwide in multiple $ billions in incremental revenue for on-market products, and have increased the pipeline NPV with 10-15%. In-depth knowledge as a clinician of (pharmaco)epidemiology, Health Economics & Outcomes Research (HEOR), Market Access, Pricing & Reimbursement, Managed Markets, companion diagnostic and bio-marker strategy, Drug Safety, Risk Management, Big Data, Data Mining algorithms, Evidence Data Generation (incl. retrospective and prospective observational studies), Health Technology Assessments, Contracting, Clinical Development strategies and processes, Biosimilars, orphan drugs, and Emerging Markets.

Vice President, Global HEOR, Pricing, Reimbursement & Market Access @ From August 2012 to Present (3 years 5 months)

Charles Gerrits is skilled in: Pharmaceutical Industry, Outcomes Research, Health Economics, Epidemiology, Pharmacoepidemiology, Clinical Development, Market Access, Lifesciences, HEOR, Strategy, Oncology, Drug Development, Clinical Research, Leadership, Clinical Trials, Biotechnology, Regulatory Affairs, Global Health, Managed Care